KSHV vIL-6 Enhances Inflammatory Responses by Epigenetic Reprogramming
暂无分享,去创建一个
C. Tepper | H. Katano | M. Shimoda | Y. Izumiya | Ryan R. Davis | Chie Izumiya | Somayeh Komaki | Ashish Kumar | Kang-Hsin Wang | Tomoki Inagaki | Hiroki Miura
[1] C. Tepper,et al. KSHV uses viral IL6 to expand infected immunosuppressive macrophages , 2023, bioRxiv.
[2] Frank Y. S. Chuang,et al. KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4 , 2022, Cell reports.
[3] Shinya Oki,et al. ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data , 2022, Nucleic Acids Res..
[4] Brad T. Sherman,et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update) , 2022, Nucleic Acids Res..
[5] T. Hirano. IL-6 in inflammation, autoimmunity and cancer , 2020, International immunology.
[6] G. Soma,et al. A unique hybrid characteristic having both pro- and anti-inflammatory phenotype transformed by repetitive low-dose lipopolysaccharide in C8-B4 microglia , 2020, Scientific Reports.
[7] Shou-Jiang Gao,et al. Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1 , 2020, Oncogene.
[8] Binqing Fu,et al. Why tocilizumab could be an effective treatment for severe COVID-19? , 2020, Journal of Translational Medicine.
[9] Ming-Ming Zhou,et al. Roles of the BRD4 short isoform in phase separation and active gene transcription , 2020, Nature Structural & Molecular Biology.
[10] Huan Gao,et al. BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling , 2020, Oncogenesis.
[11] Veronika A. Herzog,et al. Quantification of experimentally induced nucleotide conversions in high-throughput sequencing datasets , 2019, BMC Bioinform..
[12] B. Berges,et al. The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model , 2018, PloS one.
[13] Krishna Sundar Twayana,et al. Prolonged lipopolysaccharide exposure induces transient immunosuppression in BV2 microglia , 2018, Journal of cellular physiology.
[14] Daniel S. Day,et al. Coactivator condensation at super-enhancers links phase separation and gene control , 2018, Science.
[15] Jia Gu,et al. fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.
[16] Johannes Zuber,et al. Thiol-linked alkylation of RNA to assess expression dynamics , 2017, Nature Methods.
[17] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[18] Vivien A. C. Schoonenberg,et al. β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance , 2016, Cell.
[19] M. Robinson,et al. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.
[20] Mark A. Dawson,et al. BET inhibitor resistance emerges from leukaemia stem cells , 2015, Nature.
[21] David C. Norris,et al. Integrated genome browser: visual analytics platform for genomics , 2015, bioRxiv.
[22] S. Goerdt,et al. Macrophage activation in human diseases. , 2015, Seminars in immunology.
[23] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[24] D. Reinberg,et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones , 2014, Nature Structural &Molecular Biology.
[25] R. Xavier,et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.
[26] J. Stenvang,et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.
[27] Y. Guo,et al. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway , 2014, Oncogene.
[28] Arndt von Haeseler,et al. NextGenMap: fast and accurate read mapping in highly polymorphic genomes , 2013, Bioinform..
[29] H. Kung,et al. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latency-Associated Nuclear Antigen Regulates the KSHV Epigenome by Association with the Histone Demethylase KDM3A , 2013, Journal of Virology.
[30] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[31] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[32] E. Pamer,et al. Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.
[33] Martin Lundberg,et al. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood , 2011, Nucleic acids research.
[34] D. Ganem,et al. Array-Based Transcript Profiling and Limiting-Dilution Reverse Transcription-PCR Analysis Identify Additional Latent Genes in Kaposi's Sarcoma-Associated Herpesvirus , 2010, Journal of Virology.
[35] G. Sandford,et al. Determinants of Secretion and Intracellular Localization of Human Herpesvirus 8 Interleukin-6 , 2009, Journal of Virology.
[36] G. Sandford,et al. Intracellular Signaling Mechanisms and Activities of Human Herpesvirus 8 Interleukin-6 , 2008, Journal of Virology.
[37] J. Nicholas,et al. Signal Transduction by Human Herpesvirus 8 Viral Interleukin-6 (vIL-6) IsModulated by the Nonsignaling gp80 Subunit of the IL-6 Receptor Complex and Is Distinct from Signaling Induced by Human IL-6 , 2006, Journal of Virology.
[38] A. Kalita,et al. JAK/STAT3 Pathway Is Involved in Survival of Neurons in Response to Insulin-like Growth Factor and Negatively Regulated by Suppressor of Cytokine Signaling-3* , 2005, Journal of Biological Chemistry.
[39] Eric B Haura,et al. Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer , 2005, Nature Clinical Practice Oncology.
[40] Hua Yu,et al. The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.
[41] K. Garcia,et al. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. , 2004, Journal of molecular biology.
[42] A. Nicolini,et al. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis , 2003, Journal of neurochemistry.
[43] G. Feldman,et al. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. , 2003, Blood.
[44] P. Galle,et al. IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-61 , 2000, The Journal of Immunology.
[45] Y. Chang,et al. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. , 1999, Human immunology.
[46] E. Jaffe,et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.
[47] P. Heinrich,et al. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.
[48] M. Corbellino,et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. , 1997, The American journal of pathology.
[49] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[50] A. Dalgleish,et al. Kaposi's sarcoma. , 1991, British Journal of Cancer.
[51] B. Damania,et al. KSHV: pathways to tumorigenesis and persistent infection. , 2014, Advances in virus research.
[52] M. Meads,et al. Kaposi’s Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6 EVIDENCE FOR A UNIQUE AUTOCRINE SIGNALING MECHANISM* , 2004 .
[53] K. Garcia,et al. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. , 2003, Science.